Jul 2026
Prime-Target neoantigen vaccination strategy enhances neoantigen-specific T cell immunity at the tumor microenvironment in murine cold tumor models 2256928
A novel “Prime-Target” neoantigen vaccination strategy that combines subcutaneous (SQ) and intra-tumor (IT) neopeptide vaccinations with a potent adjuvant combination of K3 CpG plus c-di-AMP (K3/c-di-AMP) is proposed.
Kou Hioki, Marlous Wildemans, Youkyung Lim et al.
· Journal of Immunology · 0 citations